Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans

@inproceedings{Xie2017RiskOD,
  title={Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans},
  author={Yan Xie and Benjamin Bowe and Tingting Li and Hong Xian and Yan Yan and Ziyad Al-Aly},
  booktitle={BMJ open},
  year={2017}
}
OBJECTIVE Proton pump inhibitors (PPIs) are widely used, and their use is associated with increased risk of adverse events. However, whether PPI use is associated with excess risk of death is unknown. We aimed to examine the association between PPI use and risk of all-cause mortality. DESIGN Longitudinal observational cohort study. SETTING US Department of Veterans Affairs. PARTICIPANTS Primary cohort of new users of PPI or histamine H2 receptor antagonists (H2 blockers) (n=349 312… CONTINUE READING

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 24 CITATIONS

Adverse effects of proton pump inhibitors: fact or fake news?

  • Current opinion in gastroenterology
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

Explicit versus implicit evaluation to detect inappropriate medication use in geriatric outpatients.

  • The aging male : the official journal of the International Society for the Study of the Aging Male
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 53 REFERENCES

Association of proton pump inhibitors with risk of dementia : a pharmacoepidemiological claims data analysis

W Gomm, K vonHolt, F Thomé
  • JAMA Neurol
  • 2016

Low levels of high - density lipoprotein cholesterol increase the risk of incident kidney disease and its progression

H Xian
  • Kidney Int
  • 2016

Similar Papers

Loading similar papers…